Cryotherapy makes it possible to achieve one of the objectives of urology in the 21st century: to cure prostate cancer by preventing urinary incontinence and sexual impotence.
Prostate cancer is the most common cancer in men and the second most deadly, after lung cancer. As with other cancers, better and more precise diagnosis and the evolution of treatments are curing this disease with fewer and fewer side effects. For this to happen, the cancer must be diagnosed as soon as possible.
Thanks to improved health care and increasingly earlier urological consultation, most prostate cancers diagnosed in recent years are very early stage tumors, affecting less than 5% of the prostate volume.
In addition, the use of Multiparametric Magnetic Resonance Imaging (MRI) is becoming more and more frequent, which makes it possible to identify the location of prostate cancer that can be considered aggressive, and to direct the biopsy directly to the tumor area.
The trend in cancer removal is the gradual use of “Focal Treatment with Cryotherapy”. This technique consists of the destruction of the tumor by freezing the affected area, leaving the rest of the prostate unharmed. It can be done without admission in a Major Outpatient Surgery or with hospital discharge in the first 24 hours.
Thanks to these three premises: diagnosis of prostate cancer at earlier stages, better localization within the prostate gland by means of Magnetic Resonance Imaging, and the use of new treatments with fewer side effects; mortality from prostate cancer is decreasing.